DR.REDDY'S LABORATORIES LTD. - 500124 - Intimation On Filing Of Form 6K For The Quarter Ended December 31, 2023
Intimation on filing of Form 6k for the quarter ended December 31, 202331-01-2024
31-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of newspaper advertisement regarding unaudited financial results for the quarter and nine months ended December 31, 202331-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation in lieu of share certificate(s) reported lost/misplaced31-01-2024
Dr. Reddy's Labs Q3 Results Review - Inline; Weak U.S. Pipeline: Prabhudas Lilladher
Other expenses remain elevated as company continues to invest for building future pipeline.31-01-2024
Dr. Reddy's Labs Q3 Results Review - Yet Another Revlimid-Led Boost: Yes Securities
Management continues to hunt for assets as well as increase research and development (absolute + % of sales) to make use of Revlimid cash.31-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Audio Recordings Of The Earnings Call Conducted On January 30, 2024
Audio Recordings of the Earnings call conducted on January 30, 202431-01-2024
Dr. Reddy's Laboratories Ltd. Results Earnings Call for Q3FY24
Conference Call with Dr. Reddy's Laboratories Ltd. Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript. Management in attendance30-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated January 30, 202430-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023
Unaudited Financial results for the Quarter and Nine Months ended December 31, 202330-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Announcement under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 201530-01-2024